Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapartum sildenafil citrate for reducing fetal-distress operative birth in small or growth-restricted term pregnancies
ACTRN12621000354886Phase 3Recruiting
- Sponsor
- Mater Misericordiae University Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intrauterine growth restriction (IUGR) and Small for gestational age (SGA) comparing Sildenafil citrate with Placebo (2 arms). Primary endpoint: Emergency caesarean section for fetal distress. Started Jul 2021; status: recruiting.
02
Drugs
sildenafil
03
Conditions
intrauterine growth restriction (IUGR)Small for gestational age (SGA)
Beyond the preview
Go deeper on ACTRN12621000354886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000354886.